{"id":13649,"date":"2013-07-07T12:26:31","date_gmt":"2013-07-07T10:26:31","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13649"},"modified":"2021-07-07T12:29:00","modified_gmt":"2021-07-07T10:29:00","slug":"guirado-perich-ll-fernandez-rivera-c-torre-cisneros-j-sabater-cabrera-e-ruiz-beato-e-varela-c","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/guirado-perich-ll-fernandez-rivera-c-torre-cisneros-j-sabater-cabrera-e-ruiz-beato-e-varela-c\/","title":{"rendered":"Guirado-Perich Ll, Fern\u00e1ndez-Rivera C, Torre-Cisneros J, Sabater-Cabrera E, Ruiz-Beato E, Varela C"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13495 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/06\/pharmacoeconomics_spanish_research_articles-1.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Guirado-Perich Ll, Fern\u00e1ndez-Rivera C, Torre-Cisneros J, Sabater-Cabrera E, Ruiz-Beato E, Varela C<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">An\u00e1lisis coste-utilidad de valganciclovir durante 200 d\u00edas frente a 100 d\u00edas post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Pharmacoeconomics Span Res Art. 2013;10(1):15-25<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/link.springer.com\/article\/10.1007\/s40277-013-0002-y\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Guirado-Perich Ll, Fern\u00e1ndez-Rivera C, Torre-Cisneros J, Sabater-Cabrera E, Ruiz-Beato E, Varela C &nbsp; &nbsp; An\u00e1lisis coste-utilidad de valganciclovir durante 200 d\u00edas frente a 100 d\u00edas post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo Pharmacoeconomics Span Res Art. 2013;10(1):15-25 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,925,304],"tags":[],"class_list":["post-13649","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-nefrologia","category-pharmacoeconomics-spanish-research-articles","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13649"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13649"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13649\/revisions"}],"predecessor-version":[{"id":13650,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13649\/revisions\/13650"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}